40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
20 °P sammeln
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
20 °P sammeln
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
20 °P sammeln
Jetzt verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
20 °P sammeln
  • Format: PDF

Uniquely designed for oncologists and general practitioners, this book offers clinicians comprehensive guidelines when dealing with women at high risk for breast cancer. Written by experts in the field on the cutting edge of this research, the following questions will be answered for the reader by the end of the book:
· Who is at elevated risk for breast cancer?
· Who should be genetically screened?
· When and how often should we obtain imaging?
· What type of imaging is adequate?
· What medications are available for prevention?
· When is surgical intervention
…mehr

Produktbeschreibung
Uniquely designed for oncologists and general practitioners, this book offers clinicians comprehensive guidelines when dealing with women at high risk for breast cancer. Written by experts in the field on the cutting edge of this research, the following questions will be answered for the reader by the end of the book:

· Who is at elevated risk for breast cancer?

· Who should be genetically screened?

· When and how often should we obtain imaging?

· What type of imaging is adequate?

· What medications are available for prevention?

· When is surgical intervention appropriate?

· What lifestyle changes should be implemented to prevent this disaster?

With one in eight women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. Breast Cancer Prevention and Treatment provides a guided approach to prevention of breast cancer in women at elevated risk for this malignancy.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Lida Mina received her MD from the American University of Beirut. She is a medical oncologist and Assistant Professor of Clinical Medicine at the Indiana University School of Medicine. Dr. Mina treats patients with breast cancer as well as patients at an elevated risk of developing the disease. She is the director of the Catherine Peachy Breast Cancer Prevention Program at the Indiana University Health Simon Cancer Center.

Dr. Anna Maria Storniolo received her MD from Stanford University. She is a medical oncologist and Professor of Clinical Medicine at the Indiana University School of Medicine. In addition to caring for patients with all stages of breast cancer, she also sees women at elevated risk of the disease. She is the founder and executive director of the Susan G. Komen Tissue Bank at the IU Simon Cancer Center, the world's only repository of normal breast tissue.

Cindy Hunter, MS, CGC is a licensed, certified genetic counselor who has worked in the field of cancer genetic counseling since 1996. Cindy is one of the pillars of the Catherine Peachy Breast Cancer Prevention Program at the Indiana University Health Simon Cancer Center.

Dr. Kandice Ludwig received her medical degree from Louisiana State University School of Medicine. She is a practicing breast surgeon at Indiana University School of Medicine, and has been appointed Assistant Professor of Clinical Surgery. Her clinical interests include younger women with breast cancer, and management of women with high risk pathology.

Dr. Hal Kipfer received his Medical Degree at the Indiana University School of Medicine. He spent the past 10 years in a dedicated breast imaging and intervention practice with special interest in resident and fellow education, as well as breast MRI protocol development. He believes faster and shorter MRI sequences can improve value, and allow more women to benefit from screening breast MRI.